Reply to: "Comment on opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis".
作者信息
McKiernan Patrick, Bernabeu Jesus Quintero, Girard Muriel, Indolfi Giuseppe, Lurz Eberhard, Trivedi Palak
机构信息
Liver Unit and Small Bowel Transplantation, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Pediatric Hepatology and Liver Transplant Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
出版信息
JHEP Rep. 2025 Mar 25;7(6):101402. doi: 10.1016/j.jhepr.2025.101402. eCollection 2025 Jun.
Abstract
摘要
相似文献
1
Reply to: "Comment on opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis".
JHEP Rep. 2025 Mar 25;7(6):101402. doi: 10.1016/j.jhepr.2025.101402. eCollection 2025 Jun.
2
Comment on opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis.
JHEP Rep. 2025 Feb 19;7(6):101361. doi: 10.1016/j.jhepr.2025.101361. eCollection 2025 Jun.
3
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Gastroenterol Hepatol. 2024 Jul;9(7):620-631. doi: 10.1016/S2468-1253(24)00080-3. Epub 2024 May 6.
4
Pruritus in intrahepatic cholestasis of pregnancy: the role of substance p.
Rev Assoc Med Bras (1992). 2025 Jun 16;71(5):e20242025. doi: 10.1590/1806-9282.20242025. eCollection 2025.
5
Clinical and Genetic Spectra of Progressive Familial Intrahepatic Cholestasis With Normal GGT: 31 Pediatric Patients and 16 Novel Variants.
Clin Genet. 2025 Jun 19. doi: 10.1111/cge.70004.
6
Association of intrahepatic cholestasis of pregnancy with preterm birth and low birth weight in offspring: A prospective cohort and Mendelian randomization study.
J Obstet Gynaecol Res. 2025 Jun;51(6):e16348. doi: 10.1111/jog.16348.
7
Gly-βMCA modulates bile acid metabolism to reduce hepatobiliary injury in KO mice.
Am J Physiol Gastrointest Liver Physiol. 2025 Jul 1;329(1):G45-G57. doi: 10.1152/ajpgi.00044.2025. Epub 2025 May 26.
8
Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis.
JHEP Rep. 2023 Oct 27;6(1):100949. doi: 10.1016/j.jhepr.2023.100949. eCollection 2024 Jan.
9
Small intestinal bacterial overgrowth in patients with progressive familial intrahepatic cholestasis.
Acta Biochim Pol. 2014;61(1):103-7. Epub 2014 Mar 17.
10
Impact of Antiviral Treatment on Survival in HBV-Related Intrahepatic Cholangiocarcinoma Patients After Hepatectomy: A 14-Year Retrospective Follow-Up Study Based on the Propensity Score Matching Method.
Ther Clin Risk Manag. 2025 Jun 11;21:869-884. doi: 10.2147/TCRM.S520629. eCollection 2025.
本文引用的文献
1
EASL Clinical Practice Guidelines on genetic cholestatic liver diseases.
J Hepatol. 2024 Aug;81(2):303-325. doi: 10.1016/j.jhep.2024.04.006. Epub 2024 Jun 8.
2
Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis.
JHEP Rep. 2023 Oct 27;6(1):100949. doi: 10.1016/j.jhepr.2023.100949. eCollection 2024 Jan.
3
Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy.
JHEP Rep. 2023 Jul 13;5(10):100844. doi: 10.1016/j.jhepr.2023.100844. eCollection 2023 Oct.
Zotero 插件